Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Aclarion Announces First Patient Enrollments at Two Additional CLARITY Trial Sites and Provides Guidance on Expected Availability of Initial Data
-
The market is projected to reach $48.3 billion by 2030, growing at a CAGR of 43.3% during the forecast period.
-
PITTSBURGH, Jan. 05, 2026 (GLOBE NEWSWIRE) -- AllerVie Health (“Allervie”),1 recently announced a cybersecurity incident, which impacted the personal information of possibly thirty thousand...
-
PALO ALTO, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Clipto.AI, a global AI company building the next-generation On-Device Multimodal Content OS, today announced that it has raised a new funding...
-
Birmingham, England, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Hello Vitamins is thrilled to announce the launch of its new website and science-backed supplement brand. Created by a team of experienced...
-
GH001 cleared by FDA for U.S. clinical investigation, enabling U.S. subject enrollmentCompany to seek FDA alignment on global Phase 3 program replicating Phase 2b designPhase 3 initiation targeted for...
-
UNIONDALE, NY, Jan. 05, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (OTC: PRPH) today provided an update to shareholders regarding recent trading activity, its capital structure, and the...
-
DUBLIN, Jan. 02, 2026 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing...
-
PHARMACORP ANNOUNCES GRANT OF STOCK OPTIONS
-
Supporting preterm infant care through international cooperation and social responsibility initiatives.